{"id":108710,"date":"2021-05-27T05:03:18","date_gmt":"2021-05-27T05:03:18","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108710"},"modified":"2021-05-27T05:03:18","modified_gmt":"2021-05-27T05:03:18","slug":"glycogen-storage-disease-type-viii","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/","title":{"rendered":"Glycogen storage disease Type VIII"},"content":{"rendered":"<p>Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-108710","post","type-post","status-publish","format-standard","hentry","category-g"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Glycogen storage disease Type VIII - Definition of Glycogen storage disease Type VIII<\/title>\n<meta name=\"description\" content=\"Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glycogen storage disease Type VIII - Definition of Glycogen storage disease Type VIII\" \/>\n<meta property=\"og:description\" content=\"Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-27T05:03:18+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/\",\"name\":\"Glycogen storage disease Type VIII - Definition of Glycogen storage disease Type VIII\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-27T05:03:18+00:00\",\"dateModified\":\"2021-05-27T05:03:18+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glycogen storage disease Type VIII\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glycogen storage disease Type VIII - Definition of Glycogen storage disease Type VIII","description":"Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/","og_locale":"en_US","og_type":"article","og_title":"Glycogen storage disease Type VIII - Definition of Glycogen storage disease Type VIII","og_description":"Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/","og_site_name":"Glossary","article_published_time":"2021-05-27T05:03:18+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/","name":"Glycogen storage disease Type VIII - Definition of Glycogen storage disease Type VIII","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-27T05:03:18+00:00","dateModified":"2021-05-27T05:03:18+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Glycogen storage disease Type VIII is a rare genetic metabolic disorder characterized by an accumulation of glycogen in the central nervous system and can result in substantial abnormalities and dysfunction of the central nervous system. Glycogen storage disease Type VIII affects the X chromosome and results in a deficiency of a liver enzyme called phosphorylase kinase. This deficiency eventually leads to excessive deposits of glycogen in the liver (National Organization for Rare Disorders [NORD], 2001). Because it is an X-linked, recessive genetic disorder, it is more likely to be masked in females and expressed in males (NORD, 2001).","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/glycogen-storage-disease-type-viii\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Glycogen storage disease Type VIII"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108710"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108710\/revisions"}],"predecessor-version":[{"id":108711,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108710\/revisions\/108711"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108710"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108710"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}